84 related articles for article (PubMed ID: 9537073)
21. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
[TBL] [Abstract][Full Text] [Related]
22. Is interferon an "inducer" of serum amyloid A?
Maury CP; Enholm E; Teppo AM
N Engl J Med; 1983 Oct; 309(17):1060-1. PubMed ID: 6621643
[No Abstract] [Full Text] [Related]
23. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
[TBL] [Abstract][Full Text] [Related]
24. [The pathogenesis of amyloidosis. The biphasic cellular theory].
Teilum G
Ugeskr Laeger; 1969 Feb; 131(8):309-12. PubMed ID: 4181930
[No Abstract] [Full Text] [Related]
25. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.
Obici L; Raimondi S; Lavatelli F; Bellotti V; Merlini G
Arthritis Rheum; 2009 Oct; 61(10):1435-40. PubMed ID: 19790131
[No Abstract] [Full Text] [Related]
26. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic options in systemic AL amyloidosis.
van Gameren II; Lokhorst H; Hazenberg BP; Vellenga E
Neth J Med; 2004 Apr; 62(4):106-13. PubMed ID: 15255079
[TBL] [Abstract][Full Text] [Related]
28. Systemic AA-amyloidosis in a European wild boar (Sus scrofa) suffering from generalized tuberculosis.
Segalés J; Vicente J; Luján L; Toussaint MJ; Gruys E; Gortázar C
J Vet Med A Physiol Pathol Clin Med; 2005 Apr; 52(3):135-7. PubMed ID: 15836445
[TBL] [Abstract][Full Text] [Related]
29. The systemic amyloidoses: an overview.
Falk RH; Skinner M
Adv Intern Med; 2000; 45():107-37. PubMed ID: 10635047
[No Abstract] [Full Text] [Related]
30. From renal amyloid deposits to the identification of the culprit genes.
Pirson Y
J Nephrol; 2003; 16(3):427-30. PubMed ID: 12832746
[TBL] [Abstract][Full Text] [Related]
31. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
[TBL] [Abstract][Full Text] [Related]
32. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
33. An animal model of vascular amyloidosis.
Ghiso J; Wisniewski T
Nat Neurosci; 2004 Sep; 7(9):902-4. PubMed ID: 15332087
[No Abstract] [Full Text] [Related]
34. Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats.
Hartig W; Leifsson PS; Nielsen OL
J Vet Med A Physiol Pathol Clin Med; 2005 Nov; 52(9):447-53. PubMed ID: 16268955
[TBL] [Abstract][Full Text] [Related]
35. Amyloidosis in black-footed cats (Felis nigripes).
Terio KA; O'Brien T; Lamberski N; Famula TR; Munson L
Vet Pathol; 2008 May; 45(3):393-400. PubMed ID: 18487501
[TBL] [Abstract][Full Text] [Related]
36. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
37. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
[TBL] [Abstract][Full Text] [Related]
38. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
39. Distribution of vascular amyloid in scrapie-affected sheep with different genotypes.
Ligios C; Dexter G; Spiropoulos J; Maestrale C; Carta A; Simmons MM
J Comp Pathol; 2004 Nov; 131(4):271-6. PubMed ID: 15511535
[TBL] [Abstract][Full Text] [Related]
40. The frequencies of the serum amyloid A2 alleles in healthy (Turkish, Azerbaijan and Kazakh) populations.
Taştan H; Osmanagaoglu O; Tuzun A
Genetika; 2005 Jul; 41(7):986-9. PubMed ID: 16152805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]